HL
Harding Loevner Portfolio holdings
AUM
$14.9B
This Quarter Return
+2.41%
1 Year Return
+22.61%
3 Year Return
+105.58%
5 Year Return
+159.12%
10 Year Return
+355.06%
AUM
$14.3B
AUM Growth
+$14.3B
(+3.3%)
Cap. Flow
+$364M
Cap. Flow
% of AUM
2.54%
Top 10 Holdings %
Top 10 Hldgs %
35.8%
Holding
92
New
4
Increased
33
Reduced
36
Closed
18
Top Buys
| 1 |
ICICI Bank
IBN
|
$326M |
| 2 |
Check Point Software Technologies
CHKP
|
$151M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$137M |
| 4 |
Banco Bilbao Vizcaya Argentaria
BBVA
|
$99.3M |
| 5 |
Baidu
BIDU
|
$98.7M |
Top Sells
| 1 |
AB InBev
BUD
|
$329M |
| 2 |
Wells Fargo
WFC
|
$171M |
| 3 |
AbbVie
ABBV
|
$139M |
| 4 |
Salesforce
CRM
|
$116M |
| 5 |
Amazon
AMZN
|
$107M |
Sector Composition
| 1 | Financials | 19.93% |
| 2 | Technology | 15.09% |
| 3 | Communication Services | 14.6% |
| 4 | Energy | 12.17% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Wells Fargo
WFC
$258B
| – | – |
-3,867,767
| Closed | -$171M |
|
77
Ryanair
RYAAY
$32.9B
| – | – |
-970
| Closed | -$73K |
|
78
Transocean
RIG
$2.82B
| – | – |
-218
| Closed | -$2K |
|
79
Procter & Gamble
PG
$370B
| – | – |
-800
| Closed | -$72K |
|
80
Ovintiv
OVV
$10.6B
| – | – |
-5,150
| Closed | -$54K |
|
81
Novartis
NVS
$248B
| – | – |
-980
| Closed | -$77K |
|
82
Johnson & Johnson
JNJ
$429B
| – | – |
-800
| Closed | -$95K |
|
83
Illinois Tool Works
ITW
$76.2B
| – | – |
-800
| Closed | -$96K |
|
84
Imperial Oil
IMO
$44.9B
| – | – |
-1,270
| Closed | -$40K |
|
85
Elevance Health
ELV
$72.4B
| – | – |
-800
| Closed | -$100K |
|
86
DaVita
DVA
$9.72B
| – | – |
-5
| Closed | – |
|
|
87
Salesforce
CRM
$245B
| – | – |
-1,628,435
| Closed | -$116M |
|
|
88
AB InBev
BUD
$116B
| – | – |
-2,506,201
| Closed | -$329M |
|
89
Avery Dennison
AVY
$13B
| – | – |
-600
| Closed | -$47K |
|
90
ASML
ASML
$290B
| – | – |
-720
| Closed | -$79K |
|
91
America Movil
AMX
$58.9B
| – | – |
-21,800
| Closed | -$249K |
|
|
92
AbbVie
ABBV
$374B
| – | – |
-2,207,008
| Closed | -$139M |
|